1. Hygieia, a digital insulin enhancement company, received FDA clearance for its phone app that helps optimize insulin management for patients with Type 2 diabetes.
2. Keytruda received expanded use approval for the treatment of patients with melanoma with involvement of lymph nodes.
3. Premixed vancomycin injection, which is in a ready-to-use bag, for the treatment of nonpregnant patients to treat bone infections, skin infections, infective endocarditis and more.
4. Esperoct, a hemophilia A treatment, is approved for use in adults and children to reduce the frequency of bleeding episodes.
More articles on supply chain:
Supplies of bladder cancer drug are dwindling
Washington faces critically low blood supply
An interoperable insulin pump, a first-of-its-kind tropical disease drug & more: 4 recent FDA approvals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
